| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And Head Of R&D | Director
2 companies
Nagendran Sukumar is a President And Head Of R&D at Taysha Gene Therapies, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 5 sells.
Estimated insider holdings value: $7.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | TSHA Taysha Gene Therapies, Inc. | President And Head Of R&D | Sale+OE | 200,000 | $4.71 | $942,000.00 | -16.6% | -7.6% | - | |
| Dec 1, 2025 | TSHA Taysha Gene Therapies, Inc. | President And Head Of R&D | Sale+OE | 370,172 | $4.58 | $1,695,905.72 | -15.5% | +2.3% | - | |
| Sep 10, 2025 | TSHA Taysha Gene Therapies, Inc. | President And Head Of R&D | Sale+OE | 200,000 | $3.23 | $646,000.00 | -16.6% | +63.4% | - | |
| Aug 21, 2025 | TSHA Taysha Gene Therapies, Inc. | President And Head Of R&D | Sell | 57,054 | $2.85 | $162,603.90 | -4.7% | +39.7% | - | |
| May 16, 2023 | TSHA Taysha Gene Therapies, Inc. | President And Head Of R&D | Buy | 5,000 | $0.68 | $3,400.00 | +17.1% | +207.8% | +349.4% | |
| Feb 2, 2022 | TSHA Taysha Gene Therapies, Inc. | Director | Buy | 10,000 | $8.01 | $80,100.00 | +52.0% | -44.0% | -84.6% |